Koyfin Home > Directory > Health Care > Apollo Medical Holdings Inc > EBITDA

Apollo Medical Holdings Inc EBITDA Chart (AMEH)

Apollo Medical Holdings Inc annual/quarterly EBITDA from 2016 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Apollo Medical Holdings Inc EBITDA for the quarter ending September 09, 2018 was $61m a 98.01% increase of 60m year over year
  • Apollo Medical Holdings Inc EBITDA for the last 12 months ending September 09, 2018 was $102m a 44.75% increase of 46m year over year
  • Apollo Medical Holdings Inc Annual EBITDA for 2017 was $57m a 47.54% increase of 27m from 2016
  • Apollo Medical Holdings Inc Annual EBITDA for 2016 was $30m
Other Income Statement Metrics:
  • Apollo Medical Holdings Inc Net Income for the quarter ending September 09, 2018 was $9m a -51.95% decrease of -5m year over year
  • Apollo Medical Holdings Inc Total Revenue for the quarter ending September 09, 2018 was $167m a 43.83% increase of 73m year over year
View Chart On Koyfin

Quarterly AMEH EBITDA Data

09/2018$61m
06/2018$12m
03/2018$28m
12/2017$1m
09/2017$26m
06/2017$9m
03/2017$21m
12/2016$-3m

Annual AMEH EBITDA Data

2017$57m
2016$30m